• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
    All News #Library
    Biotech

    Biodexa Announces Exclusive License of Otsuka’s OPB-171775

    GLOBENEWSWIRE

    AstraZeneca Wins CDSCO Nod for Durvalumab in Gastric Cancer

    ECONOMICTIMES

    Abbvie Seeks FDA & EMA Approval For Upadacitinib

    PRESS RELEASE

    Biologics, biosimilars are the focus of India`s $1.1B investment

    FIERCE PHARMA

    Pfizer Links Monthly GLP-1 To Competitive Weight Loss In Phase 2

    FIERCE BIOTECH

    Merck lines up $70B+ in revenue opportunities over next decade

    FIERCE PHARMA

    Roche Continues RNA Return With $1.7B Deal For Sanegene Drug

    FIERCE BIOTECH

    Twist Bio Reveals Q1 2026 Financials

    BUSINESSWIRE

    Eisai Invests $8.8M In Malaria, Tuberculosis, And NTD R&D Project

    PR NEWSWIRE

    Skye Reports Positive Cbeyond Ph 2A Extension Interim Study

    GLOBENEWSWIRE

    Neurothera Labs Receives U.S. Patent For Cannabinoid Technology

    GLOBENEWSWIRE

    Sagimet Announces Positive 52-Wk Denifanstat Data in Severe MASH

    GLOBENEWSWIRE

    Groundbreaking Therapy Targets Advanced Heart Failure

    GLOBENEWSWIRE

    EYLEA HD Injection 8 mg Presentations at Angiogenesis 2026

    GLOBENEWSWIRE

    Polaryx Therapeutics to List on Nasdaq as PLYX

    GLOBENEWSWIRE

    UK Body Says Sanofi in Breach Over RSV Therapy Against Pfizer

    REUTERS

    Personalis Expands Evidence For Ultrasensitive ctDNA Monitoring

    BUSINESSWIRE

    ORYZON Granted New Patent For Vafidemstat In Japan

    GLOBENEWSWIRE

    Oragenics to Participate in SCOPE Summit 2026

    GLOBENEWSWIRE

    Opus Genetics to Attend Feb. 2026 Medical & Industry Conferences

    GLOBENEWSWIRE

    Onchilles Pharma Secures IND for Next-Gen ELANE Cytotoxic N17350

    BUSINESSWIRE

    Abinopharm Releases AbinoNutra NMN Paper After FDA Approval

    GLOBENEWSWIRE

    Natera Submits Signatera CDx PMA to FDA

    BUSINESSWIRE

    NanoViricides President Dr. Diwan Interviewed by Mission Matters`

    PHARMIWEB

    Mwyngil Therapeutics Announces Updates On NLRP3 Portfolio

    PR NEWSWIRE

    FDA Fast-Track MoonLake`s Sonelokimab for Palmoplantar Pustulosis

    GLOBENEWSWIRE

    Definium Therapeutics Announces New Employee Inducement Grants

    BUSINESSWIRE

    Insitro Concludes AI Human Genetics Study On Brown Adipose Tissue

    BUSINESSWIRE

    ImmunityBio Launches ANKTIVA Phase 2 Trial in Indolent Lymphomas

    PHARMIWEB

    Humanetics Corporation To Present At Upcoming Investor Conference

    PHARMIWEB

    Inside Henlius` Global Growth Strategy

    FIERCE BIOTECH

    Galderma Announces FDA BLA Acceptance Of RelabotulinumtoxinA

    BUSINESSWIRE

    Ajinomoto CELLiST Launches CELLiSTTM AAV Production Efficiency

    PHARMIWEB

    FDA Accepts Exelixis` NDA for Zanzalintinib + ICI in Cancer

    BUSINESSWIRE

    Equillium Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    GLOBENEWSWIRE

    Ensem Therapeutics Initiates First Patient Dosing In China

    BUSINESSWIRE

    Edgewise Reports Inducement Grants as permitted by Nasdaq LR

    PR NEWSWIRE

    Dogwood Therapeutics Ongoing Halneuron Trial at 50%; Top Results

    GLOBENEWSWIRE

    Daiichi Stops Internal Development Of Next-Wave ADC

    FIERCE BIOTECH

    CREATE Medicines Shows B-Cell Depletion in Nonhuman Primates

    PR NEWSWIRE

    Cormedix Therapeutics Announces Share Repurchase Program

    GLOBENEWSWIRE

    Candel Therapeutics Grants Inducements Under Nasdaq 5635(c)(4)

    GLOBENEWSWIRE

    Bio-Techne Expands Stem Cell Portfolio With Synthetic Alternative

    PR NEWSWIRE

    Bavarian Nordic: Transactions in Share Buy-Back Program

    GLOBENEWSWIRE

    Eurneffy 1 mg Nasal Spray Recommended For EU Approval

    GLOBENEWSWIRE

    Arcutis Reports Positive Phase 2 Results For ZORYVE Cream

    GLOBENEWSWIRE

    Anixa Biosciences Gets USAN Council Approval For CAR-T Therapy

    PR NEWSWIRE

    Amgen Terminates Autoimmune Partnership With Kyowa Kirin

    BIOSPACE

    Alvotech Inks Biosimilar Deals in Canada, Australia, NZ

    GLOBENEWSWIRE

    Alterome Therapeutics Names Leo Faoro As Chief Medical Officer

    PHARMIWEB

    Agomab Announces Launch Of Initial Public Offering

    GLOBENEWSWIRE

    ADC Therapeutics Grants New Employees Under Inducement Plan

    PR NEWSWIRE

    Acurx Granted New USPTO Patent For DNA Polymerase IIIC Inhibitors

    PR NEWSWIRE

    Lupin, TB Alliance Partner To Advance Telacebec For TB Treatment

    PRESS RELEASE

    Novo`s Cagrisema Tops Semaglutide In Ph. 3 Diabetes Study

    FIERCE BIOTECH

    Wave Life Sciences Expedites WVE-006 Regulatory Process

    GLOBENEWSWIRE

    Budget 2026 Gives Biologics & Biosimilars A Major Policy Boost

    ECONOMICTIMES

    Biocon`s Shaw: Budget Boosts India`s Health, Innovation

    ECONOMICTIMES

    Sanyou Bio Transforms Into Original Drug Discovery Innovation Hub

    PR NEWSWIRE

    Regeneron Bets Added Cholesterol Benefit Will Help Obesity Drug

    REUTERS

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.